FEATURES OF CORRECTION THYROID HOMEOSTASIS IN PATIENTS WITH CHRONIC 78 DIFFUSE LIVERDISEASE

K.A. CHYMPOY, M. V. BOBYK, K.A. SYROTA,, I.L. NEMISH, N.D. PAVLYUKOVI

Abstract


Summary. The dynamics of indicators of thyroid homeostasis, pro-and antioxidant system in patients with chronic diffuse liver diseases using of selenium- containing drug “Triovit” has been studied. It has been established, that Triovit in the complex treatment of patients with chronic diffuse liver disease contributes to optimizing thyroid.

Refbacks

  • There are currently no refbacks.